Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cells

Kurtis E. Bachman, Jason Sager, Ian Cheong, Marco Catto, Alberto Bardelli, Ben Ho Park, Bert Vogelstein, Angelo Carotti, Kenneth W Kinzler, Christoph Lengauer

Research output: Contribution to journalArticle


The dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) is a heterocyclic amine and is a common byproduct of cooked meat and fish. Although most cells undergo apoptosis when exposed to this mutagen, subsets develop resistance. Rather than die, these resistant cells persist and accumulate mutations, thereby driving tumorigenesis of exposed organs within the gastrointestinal tract. By applying a high-throughput cell-based screen of 32,000 small molecules, we have identified a family of compounds that specifically inhibit the growth of PhIP-resistant cancer cells. These compounds may prove useful for the treatment or prevention of gastrointestinal tumors arising after exposure to PhIP and related carcinogens.

Original languageEnglish (US)
Pages (from-to)1026-1030
Number of pages5
JournalMolecular Cancer Therapeutics
Issue number6
StatePublished - Jun 2005


ASJC Scopus subject areas

  • Oncology
  • Drug Discovery
  • Pharmacology

Cite this